Early detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Patterson, James C ^a,b,c   Lilien, David L ^b   Takalkar, Amol ^b   Pinkston, James B ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Biomedical Research Foundation of Northwest Louisiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; EVALUATION; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 77957883667     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/946590     Document Type: Article

References (38)

1. Friedland R. P., Budinger T. F., Ganz E., Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose Journal of Computer Assisted Tomography 1983 7 4 590 598
2. Kemp P. M., Holmes C., Imaging in dementia with Lewy bodies: a review Nuclear Medicine Communications 2007 28 7 511 519
3. Pakrasi S., O'Brien J. T., Emission tomography in dementia Nuclear Medicine Communications 2005 26 3 189 196
4. Duara R., Grady C., Haxby J., Positron emission tomography in Alzheimer's disease Neurology 1986 36 7 879 887
5. Haxby J. V., Grady C. L., Duara R., Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia Archives of Neurology 1986 43 9 882 885
6. Small G. W., Ercoli L. M., Silverman D. H. S., Huang S.-C., Komo S., Bookheimer S. Y., Lavretsky H., Miller K., Siddarth P., Rasgon N. L., Mazziotta J. C., Saxena S., Wu H. M., Mega M. S., Cummings J. L., Saunders A. M., Pericak-Vance M. A., Roses A. D., Barrio J. R., Phelps M. E., Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2000 97 11 6037 6042
7. De Leon M. J., Convit A., Wolf O. T., Tarshish C. Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A. J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J., Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET) Proceedings of the National Academy of Sciences of the United States of America 2001 98 19 10966 10971
8. Reiman E. M., Caselli R. J., Chen K., Alexander G. E., Bandy D., Frost J., Declining brain activity in cognitively normal apolipoprotein E 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3334 3339
9. Mosconi L., Wai H. T., Pupi A., De Santi S., Drzezga A., Minoshima S., De Leon M. J., 18F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease Journal of Nuclear Medicine 2007 48 7 1129 1134
10. Patterson II J., Minagar A., Natarajan N., Takalkar A., Alzheimers disease detection with objective statistical evaluation of FDG-PET brain scans: essential methodology for early identification Future Neurology 2010 5 2 259 276
11. Zubenko G. S., Zubenko W. N., McPherson S., Spoor E., Marin D. B., Farlow M. R., Smith G. E., Geda Y. E., Cummings J. L., Petersen R. C., Sunderland T., A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease American Journal of Psychiatry 2003 160 5 857 866
12. Petersen R. C., Stevens J. C., Ganguli M., Tangalos E. G., Cummings J. L., DeKosky S. T., Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review) Neurology 2001 56 9 1133 1142
13. Friston K. J., Ashburner J., Frith C. D., Poline J.-B., Heather J. D., Frackowiak R. S. J., Spatial registration and normalization of images Human Brain Mapping 1995 3 3 165 189
14. Friston K. J., Holmes A. P., Worsley K. J., Poline J.-P., Frith C. D., Frackowiak R. S. J., Statistical parametric maps in functional imaging: a general linear approach Human Brain Mapping 1994 2 4 189 210
15. Hagberg B., Ingvar D. H., Cognitive reduction in presenile dementia related to regional abnormalities of the cerebral blood flow British Journal of Psychiatry 1976 128 3 209 222
16. Friedland R. P., Budinger T. F., Koss E., Ober B. A., Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization Neuroscience Letters 1985 53 3 235 240
17. Minoshima S., Foster N. L., Kuhl D. E., Posterior cingulate cortex in Alzheimer's disease The Lancet 1994 344 8926 895
18. Minoshima S., Giordani B., Berent S., Frey K. A., Foster N. L., Kuhl D. E., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Annals of Neurology 1997 42 1 85 94
19. de Leon M. J., Mosconi L., Blennow K., DeSanti S., Zinkowski R., Mehta P. D., Pratico D., Tsui W., Saint Louis L. A., Sobanska L., Brys M., Li Y., Rich K., Rinne J., Rusinek H., Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease Annals of the New York Academy of Sciences 2007 1097 114 145
20. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B., Cappa S., Lenz O., Ludecke S., Marcone A., Mielke R., Ortelli P., Padovani A., Pelati O., Pupi A., Scarpini E., Weisenbach S., Herholz K., Salmon E., Holthoff V., Sorbi S., Fazio F., Perani D., Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease Archives of Neurology 2005 62 11 1728 1733
21. Kimbrell T. A., Ketter T. A., George M. S., Little J. T., Benson B. E., Willis M. W., Herscovitch P., Post R. M., Regional cerebral glucose utilization in patients with a range of severities of unipolar depression Biological Psychiatry 2002 51 3 237 252
22. Binder L. M., Iverson G. L., Brooks B. L., To err is human: abnormal neuropsychological scores and variability are common in healthy adults Archives of Clinical Neuropsychology 2009 24 1 31 46
23. Jak A. J., Bondi M. W., Delano-Wood L., Wierenga C., Corey-Bloom J., Salmon D. P., Delis D. C., Quantification of five neuropsychological approaches to defining mild cognitive impairment American Journal of Geriatric Psychiatry 2009 17 5 368 375
24. Teng E., Tingus K. D., Lu P. H., Cummings J. L., Persistence of neuropsychological testing deficits in mild cognitive impairment Dementia and Geriatric Cognitive Disorders 2009 28 2 168 178
25. Bozoki A. C., An H., Bozoki E. S., Little R. J., The existence of cognitive plateaus in Alzheimer's disease Alzheimer's and Dementia 2009 5 6 470 478
26. Alexander G. E., Furey M. L., Grady C. L., Pietrini P., Brady D. R., Mentis M. J., Schapiro M. B., Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis American Journal of Psychiatry 1997 154 2 165 172
27. Minoshima S., Imaging Alzheimer's disease: clinical applications Neuroimaging Clinics of North America 2003 13 4 769 780
28. Haense C., Herholz K., Jagust W. J., Heiss W. D., Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI) Dementia and Geriatric Cognitive Disorders 2009 28 3 259 266
29. Burdette J. H., Minoshima S., Borght T. V., Tran D. D., Kuhl D. E., Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections Radiology 1996 198 3 837 843
30. Ishii K., Sasaki M., Matsui M., Sakamoto S., Yamaji S., Hayashi N., Mori T., Kitagaki H., Hirono N., Mori E., A diagnostic method for suspected Alzheimer's disease using H215O positron emission tomography perfusion Z score Neuroradiology 2000 42 11 787 794
31. Foster N. L., Heidebrink J. L., Clark C. M., Jagust W. J., Arnold S. E., Barbas N. R., DeCarli C. S., Scott Turner R., Koeppe R. A., Higdon R., Minoshima S., FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease Brain 2007 130 10 2616 2635
32. Patterson J. C. II, Lilien D. L., Takalkar A., Kelley R. E., Minagar A., Potential value of quantitative analysis of cerebral PET in early cognitive decline American Journal of Alzheimer's Disease and other Dementias 2009 23 6 586 592
33. Minoshima S., Frey K. A., Koeppe R. A., Foster N. L., Kuhl D. E., A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET Journal of Nuclear Medicine 1995 36 7 1238 1248
34. Mosconi L., Tsui W. H., Herholz K., Pupi A., Drzezga A., Lucignani G., Reiman E. M., Holthoff V., Kalbe E., Sorbi S., Diehl-Schmid J., Perneczky R., Clerici F., Caselli R., Beuthien-Baumann B., Kurz A., Minoshima S., De Leon M. J., Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias Journal of Nuclear Medicine 2008 49 3 390 398
35. Grimmer T., Diehl J., Drzezga A., Frstl H., Kurz A., Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study Dementia and Geriatric Cognitive Disorders 2004 18 1 32 36
36. Diehl J., Grimmer T., Drzezga A., Riemenschneider M., Frstl H., Kurz A., Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study Neurobiology of Aging 2004 25 8 1051 1056
37. Herholz K., PET studies in dementia Annals of Nuclear Medicine 2003 17 2 79 89
38. Ishii K., Soma T., Kono A. K., Sofue K., Miyamoto N., Yoshikawa T., Mori E., Murase K., Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease Journal of Nuclear Medicine 2007 48 5 704 711